1210014

Northland Nuclear Medicine, LLC — FEI 3005334016

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
July 13, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Bismarck, ND (United States)

Citations

IDCFRDescription
1781221 CFR 212.50Adequate controls (general)
1782121 CFR 212.50(b)(6)Action limits on radiochemical yield
2137321 CFR 212.30(b)Equipment procedures